Precision BioSciences (DTIL) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 21, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by May 20, 2026.

Voting matters and shareholder proposals

• Election of two Class I directors: Melinda Brown and Geno Germano.

• Ratification of Deloitte & Touche LLP as independent auditor for 2026.

• Advisory approval of executive compensation (say-on-pay vote).

• Approval of amendment and restatement of the 2019 Incentive Award Plan.

• Amendment to Certificate of Incorporation for officer exculpation under Delaware law.

• Approval to adjourn the meeting if additional proxy solicitation is needed.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals and director nominees.